Study Clears Vaginal Estrogen of Recurrent Stroke Risk After Menopause

Study Clears Vaginal Estrogen of Recurrent Stroke Risk After Menopause

(MedPage Today) -- Researchers saw no link between vaginal estrogen therapy and recurrent strokes, despite concerns that the hormone is systemically absorbed. In a case-control study of female stroke survivors across Denmark, there was no such...

Study reassures safety of vaginal estrogen tablets for women with prior stroke

No link between vaginal estrogen tablet use and recurrent stroke was observed in a cohort of women with a history of stroke, regardless of current or past use of the hormone therapy or dose, researchers reported.Results from a Danish nationwide study evaluating the impact of vaginal estradiol on recurrent stroke risk was published in Stroke.

Vaginal estrogen tablets not linked with increased risk of recurrent ischemic stroke

“We hope our findings reassure health professionals caring for postmenopausal women with a history of stroke,” says Kimia Ghias Haddadan, MD.

Vaginal estrogen tablets not linked to recurrent stroke risk in postmenopausal women

Vaginal estrogen tablets were not associated with increased risk of recurrent ischemic stroke in postmenopausal women with prior stroke.

Vaginal Estrogen and Recurrent Stroke Risk: Time to Remove FDA Warning?

Vaginal estrogen does not raise recurrent stroke risk in postmenopausal women, bolstering calls from experts to remove the ‘inappropriate’ boxed warning on these products.

Vaginal Estrogen Tablets Show Safety Potential for Postmenopausal Stroke

In a groundbreaking nationwide study conducted in Denmark, researchers have uncovered compelling evidence that vaginal estrogen tablets may not elevate the risk of recurrent ischemic stroke in postmenopausal women who have already experienced a stroke. Published in the esteemed journal Stroke, this study addresses a critical knowledge gap concerning the safety profile of vaginal estrogen […]